You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Nitric Oxide-Releasing Intranasal Gel To Decolonize Biofilm-embedded S. Aureus

    SBC: Novan, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Staphylococcus aureus is the second leading cause of hospital-acquired bloodstream infections. In 2003, nearly 300,000 patients in US hospitals acquired an S. aureus infection, which accounted for nearly three million days of hospitalization, 9.5 billion in excess costs, and at least 12,000 inpatient deaths. Additionally, approximately 50% of the US population ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  2. Rapid Response Vaccines for Botulinum Neurotoxins

    SBC: Iterative Therapeutics Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): Botulinum neurotoxins (BoNTs) are the most potent protein toxins known. Given their potent toxicity and their potential use in bio-warfare scenarios, BoNTs are included among the Category A select agents. The currentlyavailable pentavalent toxoid vaccine requires multiple boosters before being effective, and protects unequally against the different BoNT serotyp ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Development of a human skeletal muscle cell-based high throughput screen for musc

    SBC: Zen-Bio, Inc.            Topic: NIAMS

    DESCRIPTION (provided by applicant): Skeletal muscle wasting is a serious condition prevalent in the aging population (sarcopenia) and in a variety of specific diseases. This condition results in loss of muscle function through impaired muscle regeneration, resulting in an increase in falls and injuries, a loss of independence, and a reduced quality of life. These changes produce a large health ca ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  4. Multifunctional Peptides for (MRI) Imaging

    SBC: CDG THERAPEUTICS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Our overall goal is to expand the role of CPPs in molecular imaging at the patient level using large animal models of human tumors and a peptide agent that inherently provides 1) preferential access to a wide variety ofhuman solid (and hematologic) tumor cells, 2) an increased intracellular concentration (2-12 fold) over histologically matched normal cells, and ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  5. Optimal Prevention and Control of Periodontal Disease: The Periodontal Pocket Irr

    SBC: C. PAXTON DESIGNS INC.            Topic: NIDCR

    DESCRIPTION (provided by applicant): Periodontal disease is a chronic bacterial infection that affects the gums and bone that surrounds supported teeth. According to the NIH fact sheet an estimated 80 percent of American adults have some form of periodontal disease. Gingivitis, a milder form of gum disease, is caused by plaque bio-film, which surrounds the teeth at the base of the gum line, causin ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  6. Bone cements for delivery of osteoinductive growth factors

    SBC: AFFINERGY, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): Bone cements are widely used in maxillofacial surgery, repair of cranial defects, and dental fillings. Calcium phosphate bone cements are useful in many types of bone repair because they conform to the defect area, harden in situ, and can be resorbed and replaced by new bone. When the cements are injectable, they can also be used for minimally invasive surgery ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  7. Impact of digital media-based nutrition education on low science literacy, under-

    SBC: CARA CAIRNS DESIGN, LLC            Topic: NIDDK

    DESCRIPTION (provided by applicant): The purpose of this project is to research and develop digital media-based nutrition education materials for low science literacy, underserved, and minority patients receiving dialysis treatment for ESRD. The developedmaterials will lay the foundation and serve as prototypes for a Phase II NIH SBIR application aimed at full development and marketing of an inter ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. Improving Obesity Outcomes through Interactive Web-Based Clinical Skills Training

    SBC: Clinical Tools, Inc            Topic: NIDDK

    DESCRIPTION (provided by applicant): Though the USPSTF recommends all clinicians intervene with obese adults (AHRQ, 2003), less than half of patients are assessed, counseled, or otherwise treated for obesity. This project will create an innovative web-based continuing professional development program for primary care providers (PCPs) available at: //www.ImpactObesity.com to improve PCP care of obe ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  9. Improving Host Response to Implantable Glucose Sensors via Nitric Oxide Release

    SBC: Novan, Inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Approximately 24 million adults and children in the United States have 1 Diabetes Mellitus (diabetes) and 1.6 million new cases are diagnosed each year. Type 2 is the most common form of the disease accounting for over90% of the diabetics worldwide. The remaining 5 to 10% of diabetics are plagued with the more serious Type 1 condition which is most often diagno ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  10. New drug Vida-5 for treating chronic kidney disease progression

    SBC: Vidasym, Inc            Topic: NIDDK

    DESCRIPTION (provided by applicant): Twenty-six million people in America have chronic kidney disease (CKD). Anemia, cardiovascular diseases, secondary hyperparathyroidism, renal osteodystrophy and other complications are common in CKD. Current treatmentsincluding ACE inhibitors for CKD patients mainly focus on managing symptoms and disease complications. Despite the various treatments available, ...

    SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government